WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Ownership - Who owns Janux Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Janux Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Alan CampbellPresident and CEO2026-07-087,000$4.21
$29.47kBuy
Janeen Noel DoyleChief Corp. Bus. Dev. Ofcr2026-06-024,059$14.03
$56.94kSell
Maria DobekVice President Accounting2026-05-112,038$14.17
$28.88kSell
Zachariah McIverChief Medical Officer2026-01-022,714$13.73
$37.26kSell
David Alan CampbellPresident and CEO2026-01-028,072$13.73
$110.83kSell
Thomas DiraimondoChief Scientific Officer2026-01-022,505$13.73
$34.39kSell
Maria DobekVice President Accounting2026-01-021,462$13.73
$20.07kSell
Andrew Hollman MeyerChief Business Officer2026-01-021,879$13.73
$25.80kSell
Charles M. WinterChief Technical Officer2026-01-022,401$13.73
$32.97kSell
Andrew Hollman MeyerChief Business Officer2025-12-01633$33.53
$21.22kSell

1 of 2

JANX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JANX insiders and whales buy or sell their stock.

JANX Shareholders

What type of owners hold Janux Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Avalon Ventures XI LP19.39%11,857,257$194.93MInsider
Jay Lichter18.06%11,040,308$181.50MInsider
Tighe Reardon14.11%8,628,172$141.85MInsider
Bregua Corp6.13%3,749,250$61.64MInsider
Ra Capital Management LP1.71%1,048,406$17.24MInsider
David Alan Campbell0.43%264,742$4.35MInsider
Orbimed Advisors LLC0.38%231,098$3.80MInsider
Peter A. Thompson0.38%231,098$3.80MInsider
Thomas Diraimondo0.25%155,825$2.56MInsider
Sheila Gujrathi0.19%118,889$1.95MInsider

1 of 3

JANX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JANX0.10%62.15%Net SellingNet Buying
KURA0.10%11.19%Net SellingNet Buying
ANL0.01%9.11%Net SellingNet Selling
ABUS0.05%99.95%
SLBT0.00%0.68%
View Top Biotech Stocks

Janux Therapeutics Stock Ownership FAQ

Who owns Janux Therapeutics?

Janux Therapeutics (NASDAQ: JANX) is owned by 0.10% institutional shareholders, 62.15% Janux Therapeutics insiders, and 37.75% retail investors. Avalon Ventures XI LP is the largest individual Janux Therapeutics shareholder, owning 11.86M shares representing 19.39% of the company. Avalon Ventures XI LP's Janux Therapeutics shares are currently valued at $192.62M.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.